Forbion Growth III Management B.V.'s Form 4 filing
Braveheart Bio, Inc. (BRVE) · filed Aug 7, 2026
- Accession no.
- 0001193125-26-340528
- Filed
- Aug 7, 2026, 5:25 PM ET
- Trade date
- Aug 7, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market purchases total $64.8M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Forbion Growth III Management B.V.CIK 0002050893 | 10% Owner |
| Forbion Growth Opportunities Fund III Cooperatief U.A.CIK 0002050895 | 10% Owner |
| Forbion Ventures Fund VII Cooperatief U.A.CIK 0002148128 | 10% Owner |
| Forbion Ventures VII Management B.V.CIK 0002148132 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | CConversionAcquired | +9,132,420 | $0.00 | $0 | 9,720,546 | Direct | |
| Aug 7, 2026 | Common Stock | CConversionAcquired | +7,990,867 | $0.00 | $0 | 8,505,478 | Indirect | |
| Aug 7, 2026 | Common Stock | PPurchaseAcquired | +1,920,000 | $18.00 | +$34,560,000 | 11,640,546 | Direct | |
| Aug 7, 2026 | Common Stock | PPurchaseAcquired | +1,680,000 | $18.00 | +$30,240,000 | 10,185,478 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | CConversionDisposed | −9,132,420 | $0.00 | $0 | 0 | Direct | |
| Aug 7, 2026 | Common Stock | CConversionDisposed | −7,990,867 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.